Literature DB >> 18523242

Noncytotoxic functions of NK cells: direct pathogen restriction and assistance to adaptive immunity.

Till Strowig1, Fabienne Brilot, Christian Münz.   

Abstract

Natural killer cells were named after their ability to mediate spontaneous cytotoxicity during innate immune responses. However, it has become clear in recent years that they play an equally important role in restricting infections and assisting the development of adaptive immune responses via their ability to produce cytokines. In humans, a dedicated NK cell subset primarily fulfills these later functions. In this review we discuss the noncytotoxic effector functions of NK cells and how they could be harnessed for immunotherapy and vaccine development.

Entities:  

Mesh:

Year:  2008        PMID: 18523242      PMCID: PMC2575662          DOI: 10.4049/jimmunol.180.12.7785

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  85 in total

Review 1.  Dendritic cells and the control of immunity.

Authors:  J Banchereau; R M Steinman
Journal:  Nature       Date:  1998-03-19       Impact factor: 49.962

2.  Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo.

Authors:  N C Fernandez; A Lozier; C Flament; P Ricciardi-Castagnoli; D Bellet; M Suter; M Perricaudet; T Tursz; E Maraskovsky; L Zitvogel
Journal:  Nat Med       Date:  1999-04       Impact factor: 53.440

Review 3.  Natural killer cells in antiviral defense: function and regulation by innate cytokines.

Authors:  C A Biron; K B Nguyen; G C Pien; L P Cousens; T P Salazar-Mather
Journal:  Annu Rev Immunol       Date:  1999       Impact factor: 28.527

Review 4.  Cellular responses to interferon-gamma.

Authors:  U Boehm; T Klamp; M Groot; J C Howard
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

5.  Characterization of early IL-12, IFN-alphabeta, and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection.

Authors:  J S Orange; C A Biron
Journal:  J Immunol       Date:  1996-06-15       Impact factor: 5.422

6.  An absolute and restricted requirement for IL-12 in natural killer cell IFN-gamma production and antiviral defense. Studies of natural killer and T cell responses in contrasting viral infections.

Authors:  J S Orange; C A Biron
Journal:  J Immunol       Date:  1996-02-01       Impact factor: 5.422

7.  Distinct role of antigen-specific T helper type 1 (Th1) and Th2 cells in tumor eradication in vivo.

Authors:  T Nishimura; K Iwakabe; M Sekimoto; Y Ohmi; T Yahata; M Nakui; T Sato; S Habu; H Tashiro; M Sato; A Ohta
Journal:  J Exp Med       Date:  1999-09-06       Impact factor: 14.307

8.  Interferon gamma regulates acute and latent murine cytomegalovirus infection and chronic disease of the great vessels.

Authors:  R M Presti; J L Pollock; A J Dal Canto; A K O'Guin; H W Virgin
Journal:  J Exp Med       Date:  1998-08-03       Impact factor: 14.307

9.  Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration.

Authors:  J S Orange; B Wang; C Terhorst; C A Biron
Journal:  J Exp Med       Date:  1995-10-01       Impact factor: 14.307

Review 10.  Biology of natural killer cells.

Authors:  G Trinchieri
Journal:  Adv Immunol       Date:  1989       Impact factor: 3.543

View more
  67 in total

1.  Cell-to-cell contact with hepatitis C virus-infected cells reduces functional capacity of natural killer cells.

Authors:  Joo Chun Yoon; Jong-Baeck Lim; Jeon Han Park; Jae Myun Lee
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

2.  A CD8α(-) subpopulation of macaque circulatory natural killer cells can mediate both antibody-dependent and antibody-independent cytotoxic activities.

Authors:  Diego A Vargas-Inchaustegui; Thorsten Demberg; Marjorie Robert-Guroff
Journal:  Immunology       Date:  2011-11       Impact factor: 7.397

3.  Chronic alcohol consumption decreases the percentage and number of NK cells in the peripheral lymph nodes and exacerbates B16BL6 melanoma metastasis into the draining lymph nodes.

Authors:  Hui Zhang; Zhaohui Zhu; Gary G Meadows
Journal:  Cell Immunol       Date:  2010-10-25       Impact factor: 4.868

4.  Functional invariant NKT cells in pig lungs regulate the airway hyperreactivity: a potential animal model.

Authors:  Gourapura J Renukaradhya; Cordelia Manickam; Mahesh Khatri; Abdul Rauf; Xiangming Li; Moriya Tsuji; Gireesh Rajashekara; Varun Dwivedi
Journal:  J Clin Immunol       Date:  2010-11-02       Impact factor: 8.317

Review 5.  Hidden talents of natural killers: NK cells in innate and adaptive immunity.

Authors:  Megan A Cooper; Marco Colonna; Wayne M Yokoyama
Journal:  EMBO Rep       Date:  2009-09-04       Impact factor: 8.807

Review 6.  Natural killer cell receptors and their ligands in liver diseases.

Authors:  Satoshi Yamagiwa; Hiroteru Kamimura; Takafumi Ichida
Journal:  Med Mol Morphol       Date:  2009-03-18       Impact factor: 2.309

Review 7.  Biology and clinical effects of natural killer cells in allogeneic transplantation.

Authors:  Jonathan E Benjamin; Saar Gill; Robert S Negrin
Journal:  Curr Opin Oncol       Date:  2010-03       Impact factor: 3.645

Review 8.  Regulatory NK-cell functions in inflammation and autoimmunity.

Authors:  Anna Lünemann; Jan D Lünemann; Christian Münz
Journal:  Mol Med       Date:  2009-05-11       Impact factor: 6.354

9.  Activating receptors promote NK cell expansion for maintenance, IL-10 production, and CD8 T cell regulation during viral infection.

Authors:  Seung-Hwan Lee; Kwang-Sin Kim; Nassima Fodil-Cornu; Silvia M Vidal; Christine A Biron
Journal:  J Exp Med       Date:  2009-08-31       Impact factor: 14.307

10.  Low NKp30, NKp46 and NKG2D expression and reduced cytotoxic activity on NK cells in cervical cancer and precursor lesions.

Authors:  Trinidad Garcia-Iglesias; Alicia Del Toro-Arreola; Benibelks Albarran-Somoza; Susana Del Toro-Arreola; Pedro E Sanchez-Hernandez; Maria Guadalupe Ramirez-Dueñas; Luz Ma Adriana Balderas-Peña; Alejandro Bravo-Cuellar; Pablo C Ortiz-Lazareno; Adrian Daneri-Navarro
Journal:  BMC Cancer       Date:  2009-06-16       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.